Figure 2.
Median concentration-time curves of (A) lufotrelvir and (B) PF-00835231 (active moiety) following multiple ascending doses of lufotrelvir. The dotted line in panel B is the EC90 of 463 ng/mL for SARS-CoV-2. MAD, multiple ascending dose.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.